Webinar | Optimising schistosomiasis treatment for preschool-aged children: A pragmatic approach from research to practice

This webinar shared findings from an important clinical trial in Uganda which evaluated the safety and efficacy of praziquantel at 40 mg/kg versus 80 mg/kg in preschool-aged children with intestinal schistosomiasis. The study found both doses were safe, with higher efficacy observed at 80 mg/kg, providing critical evidence to guide treatment strategies for young children in endemic regions. The webinar discussed these findings and how they can contribute to a practical approach to include preschool-aged children in schistosomiasis control and elimination efforts.